Steven J Hardy
Overview
Explore the profile of Steven J Hardy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hardy S, Connolly M, Forman S, Nickel R
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31511.
PMID: 39800879
Background: Sickle cell disease (SCD) confers neurological risks that contribute to cognitive and academic difficulties. Clinical guidelines state that cognition should be monitored using signaling questions. However, evidence is lacking...
2.
Hardy S, Crosby L, Porter J, Sil S, Valrie C, Jonassaint C, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2429443.
PMID: 39167410
Importance: The introduction of gene therapies into the clinical care landscape for individuals living with sickle cell disease (SCD) represents a momentous achievement with the potential to rewrite the story...
3.
Connolly M, Forman S, Sharkey C, Merwin S, Darbari D, Hardy S
Pediatr Blood Cancer
. 2023 Sep;
70(12):e30667.
PMID: 37726889
Background: Sickle cell disease (SCD) pain is associated with functional impairment, and treatment is often limited to pharmacological approaches with unwanted side effects. Although behavioral interventions exist for non-SCD pain...
4.
Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
Hoyt C, Heitzer A, Hardy S
Blood Adv
. 2023 Apr;
7(14):3680-3682.
PMID: 37058485
No abstract available.
5.
Hardy S, Williams Z, Berger C, Griffin D, Weisman H, Liang H, et al.
Pediatr Blood Cancer
. 2023 Apr;
70(6):e30346.
PMID: 37026487
Background: Youth with sickle cell disease (SCD) experience increased rates of neurocognitive and emotional difficulties. Cross-sectional studies suggest neurocognitive and emotional functioning are associated with health outcomes in SCD. We...
6.
Hardy S, Forman S, Hardy K, Schatz J
Front Neurol
. 2022 Jul;
13:867437.
PMID: 35873765
Background: Sickle cell disease (SCD) imparts risk for a range of neurodevelopmental and neurocognitive disorders. Sluggish cognitive tempo (SCT) is a distinct syndrome that often co-occurs with attention-deficit/hyperactivity disorder (ADHD)...
7.
Wang Y, Hardy S, Ichesco E, Zhang P, Harris R, Darbari D
Transl Res
. 2021 Aug;
240:17-25.
PMID: 34418575
Pain is the most common symptom experienced by patients with sickle cell disease (SCD) and is associated with poor quality of life. We investigated the association between grey matter volume...
8.
Reece-Stremtan S, Mahmood L, Margulies S, Martin B, Rohatgi R, Idiokitas R, et al.
J Pain Symptom Manage
. 2021 Jun;
62(6):1239-1244.
PMID: 34118373
Context: Acute episodes of pain associated with sickle cell disease (SCD) account for over 100,000 hospitalizations and expenses of nearly one billion dollars annually in the U.S. New treatment approaches...
9.
Hardy S, Bills S, Meier E, Schatz J, Keridan K, Wise S, et al.
J Pediatr Psychol
. 2021 Apr;
46(8):1001-1014.
PMID: 33824980
Objective: Youth with sickle cell disease (SCD) are at risk for neurocognitive deficits including problems with working memory (WM), but few interventions to improve functioning exist. This study sought to...
10.
Connolly M, Bills S, Hardy S
J Pediatr Hematol Oncol
. 2021 Feb;
43(5):e666-e676.
PMID: 33625087
Children with sickle cell disease (SCD) face academic challenges because of direct and indirect disease-related events. This study examined the proportion of youth with SCD with educational plans and whether...